trajenta

cardiovascular,CAROLINA,Trajenta

Full data from CAROLINA® outcome trial support long-term cardiovascular safety profile of Trajenta®

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced full data from the CAROLINA

Read More